Legislation
Take Action: Ask congress to require domain name sellers to take down websites that sell drugs illegally
The “Domain Reform for Unlawful Drug Sellers” or “DRUGS” Act would require domain name sellers to lock and suspend websites when regulators or law enforcement show evidence that they are selling drugs illegally.
This would be a game changer for patient safety.
Partnership for Safe Medicines’ Statement on Congressional Action to Permanently Schedule Fentanyl-Related Analogues and Substances
Shabbir Safdar, Executive Director of the Partnership for Safe Medicines, released the following statement today in response to Congressional actions to permanently scheduling illicitly manufactured and deadly fentanyl…
[...]The Safeguarding Therapeutics Act passes the House Energy and Commerce Committee with full support
The House Energy and Commerce Committee marked up and passed H.R. 5663, the Safeguarding Therapeutics Act, today.
[...]Eight Surprising Things We Learned from Reading the 1,200 Comments Filed with the FDA on Canadian Drug Importation
For 78 days, the Department of Health and Human Services accepted public comment on the proposed rulemaking that would allow states to establish drug importation programs, individuals and organizations submitted 1,210 comments, and PSM read each of them. Here are what we feel are the most important takeaways…
[...]House Resolution demands open access to WHOIS Results
WHOIS data is searchable registrar information available for all websites on the Internet. It has long been used to trace criminal websites that host counterfeit and illicit drug sales, human trafficking, child pornography, and illicit and copyrighted content, as well as the websites of spammers, denial-of-services and phishing attackers, and other fraudsters.
[...]New Jersey Enacts Increased Penalties for Counterfeit Drug Crimes
The Governor of New Jersey has just signed A-5037, a new law designed to increase penalties for counterfeit drug crimes committed in the state.
[...]Drug Importation Claim vs. Fact At Florida Senate Subcommittee Hearing
Experts and leadership from The Partnership for Safe Medicines were in Tallahassee, Florida on Monday, March 25th for a Senate hearing on an ill-advised Canadian drug importation bill. During the hearing, our team heard many false or misleading statements about the proposal to take medicine out of the Canadian medicine supply and ship it to Florida. Here’s a fact check of the most egregious ones…
[...]Florida House Bill 19 Would Expose Patients To Unregulated Prescription Drugs
Concerns over how much constituents pay for their medications have caused multiple states to introduce bills that would legalize drug importation. Florida’s House Bill 19 is just one example of legislators thinking that stepping outside the security of the U.S.’s drug supply chain is a smart option for their state…
[...]Former FBI Director Louis Freeh Updates His 2017 Report on the Threat of Congressional Drug Importation Proposals
Former FBI Director Louis Freeh has released an addendum to his 2017 Report on the Potential Impact of Drug Importation Proposals on U.S. Law Enforcement, concluding:
…the government has not done enough to evaluate and improve the capacity of law enforcement to deal with a new pipeline of drugs into the U.S. drug supply, all while . . . more illegal drugs are being shipped to the United States. Passing any drug importation scheme would erase the little progress we have made and set law enforcement further back on their heels.
[...]Importation Is Too Risky, Warns Former FDA Associate Commissioner
In a January 23, 2019 editorial published in The Hill Peter Pitts, a former FDA associate commissioner and the president of the Center for Medicine in the Public Interest, explains why the safety risks of importation far outweigh any savings.
[...]